Nandan Kulkarni

Stock Analyst at Bernstein

(1.68)
# 3,447
Out of 5,074 analysts
3
Total ratings
100%
Success rate
5.9%
Average return

Stocks Rated by Nandan Kulkarni

Mankind Pharma Limited
Oct 16, 2026
Reiterated: Sell
Price Target: ₹2,057
Current: ₹2,245
Upside: -8.37%